| The Coming Age of the Über-Athlete: What's So Bad about Gene Enhancement and Doping? |
 |
|
|
 |
| Start: |
Thursday, December 18, 2008
9:00 AM
|
 |
| End: |
Thursday, December 18, 2008
3:30 PM
|
 |
| Location: |
Wohlstetter Conference Center, Twelfth Floor, AEI 1150 Seventeenth Street, N.W., Washington, D.C. 20036 Directions to AEI |
 |
It is said to be sports' doomsday scenario: a new generation of chemically enhanced or bioengineered athletes transformed from also-rans into world champions. We are entering an age often referred to as posthumanist, and sport is its leading edge. Elite athletes regularly remake their bodies in an effort to stretch human performance, benefiting from dramatic advances in medical technology, reconstructive surgery, and drug therapy. Most physiologists, ethicists, and sport authorities have attempted to draw a line--one that critics say is hazy and unenforceable--that makes certain performance-enhancing drugs and gene manipulation off limits. But the reaction to the Mitchell Report, the investigation commissioned by former senator George J. Mitchell into the use of steroids by Major League Baseball players, indicates that the public is less critical and far more ambivalent about how--or even whether--to control gene and drug enhancement.
Should gene manipulation and drugs be permitted to alter the mythical "level playing field" of life? Should humans be allowed or even encouraged to change their natural athletic endowments, and, if so, would that open the way for manipulating other innate characteristics? Considering that sports are heavily subsidized by governments and what occurs on the playing field is often a leading indicator for the exploitation of new technologies, what implications does this coming era of the über-athlete have for society and public policy? |
 |
|
8:45 a.m. |
Registration |
|
|
|
|
|
|
9:00 |
Introduction: |
|
|
|
|
|
|
9:10 |
Opening Remarks: |
Travis Tygart, U.S. Anti-Doping Agency |
|
|
|
|
|
10:00 |
|
Panel I: Athletes under the Microscope |
|
|
|
|
|
|
Panelists: |
Dionne Koller, University of Baltimore School of Law |
|
|
|
John Ruger, United States Olympic Committee |
|
|
|
Kicker Vencill, elite swimmer |
|
|
|
|
|
|
Moderator: |
Jon Entine, AEI |
|
|
|
|
|
11:15 |
|
Panel II: Drug Testing and Policy |
|
|
|
|
|
|
Panelists: |
Theodore Friedman, University of California, San Diego |
|
|
|
Paul Haagen, Duke University Center for Sports Law and Policy |
|
|
|
|
|
Moderator: |
Randy Mayes, Triple Helix |
|
|
|
|
|
12:30 p.m. |
Luncheon |
|
|
|
|
|
|
1:00 |
Keynote Address: |
Edwin Moses, Laureus World Sports Academy |
|
|
|
|
|
2:00 |
|
Panel III: Drugs, Genes, and the Future of Sports |
|
|
|
|
|
|
Panelists: |
Andy Miah, University of the West of Scotland |
|
|
|
Thomas Murray, Hastings Center |
|
|
|
|
|
|
Discussants: |
Theodore Friedman, University of California, San Diego |
|
|
|
Paul Haagen, Duke University Center for Sports Law and Policy |
|
|
|
|
|
|
Moderator: |
|
|
|
|
|
|
3:30 p.m. |
Adjournment |
| |
 |
More Information
Jon Flugstad American Enterprise Institute 1150 Seventeenth Street, N.W. Washington, DC 20036 Phone: 202-862-4878 E-mail: jon.flugstad@aei.org
|
Media Inquiries
Veronique Rodman American Enterprise Institute 1150 Seventeenth Street, N.W. Washington, DC 20036 Phone: 202-862-4870 E-mail: VRodman@aei.org
|
|
 |
| AEI Print Index No. 23757 |
|
 |
|
 |